Advertisement
Screener

Faeth Therapeutics, Inc. (FTH) Other

Faeth Therapeutics, Inc. Other

Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.

  • 2026-06-02: Form 10-K/A; Item Stock registered under Section 12(b); As filed Common Stock, $0.0001 par value per share · SNSE · NASDAQ.
  • 2026-05-15: Form 10-Q; Item Stock registered under Section 12(b); As filed Common Stock, $0.0001 par value per share · SNSE · NASDAQ.
  • 2026-03-30: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock, $0.0001 par value per share · SNSE · NASDAQ.
  • 2025-11-14: Form 10-Q; Item Stock registered under Section 12(b); As filed Common Stock, $0.0001 par value per share · SNSE · NASDAQ.
FiledFormItemAs filed
2026-06-0210-K/AStock registered under Section 12(b)Common Stock, $0.0001 par value per share · SNSE · NASDAQ
2026-05-1510-QStock registered under Section 12(b)Common Stock, $0.0001 par value per share · SNSE · NASDAQ
2026-03-3010-KStock registered under Section 12(b)Common Stock, $0.0001 par value per share · SNSE · NASDAQ
2025-11-1410-QStock registered under Section 12(b)Common Stock, $0.0001 par value per share · SNSE · NASDAQ
2025-08-0510-QStock registered under Section 12(b)Common Stock, $0.0001 par value per share · SNSE · NASDAQ
2025-05-0610-QStock registered under Section 12(b)Common Stock, $0.0001 par value per share · SNSE · NASDAQ
2025-03-2810-KStock registered under Section 12(b)Common Stock, $0.0001 par value per share · SNSE · NASDAQ
2024-11-1410-QSecurity registered under Section 12(b)Series A Preferred Stock Purchase Rights · NASDAQ
2024-11-1410-QStock registered under Section 12(b)Common Stock, $0.0001 par value per share · SNSE · NASDAQ
2024-08-0610-QSecurity registered under Section 12(b)Series A Preferred Stock Purchase Rights · NASDAQ
2024-08-0610-QStock registered under Section 12(b)Common Stock, $0.0001 par value per share · SNSE · NASDAQ
2024-05-0910-QSecurity registered under Section 12(b)Series A Preferred Stock Purchase Rights · NASDAQ
2024-05-0910-QStock registered under Section 12(b)Common Stock, $0.0001 par value per share · SNSE · NASDAQ
2024-02-2910-KSecurity registered under Section 12(b)Series A Preferred Stock Purchase Rights · NASDAQ
2024-02-2910-KStock registered under Section 12(b)Common Stock, $0.0001 par value per share · SNSE · NASDAQ
2023-11-0710-QSecurity registered under Section 12(b)Series A Preferred Stock Purchase Rights · NASDAQ
2023-11-0710-QStock registered under Section 12(b)Common Stock, $0.0001 par value per share · SNSE · NASDAQ
2023-08-0310-QSecurity registered under Section 12(b)Series A Preferred Stock Purchase Rights · NASDAQ
2023-08-0310-QStock registered under Section 12(b)Common Stock, $0.0001 par value per share · SNSE · NASDAQ
2023-05-0910-QSecurity registered under Section 12(b)Series A Preferred Stock Purchase Rights · NASDAQ
2023-05-0910-QStock registered under Section 12(b)Common Stock, $0.0001 par value per share · SNSE · NASDAQ
2023-05-0110-K/ASecurity registered under Section 12(b)Series A Preferred Stock Purchase Rights · NASDAQ
2023-05-0110-K/AStock registered under Section 12(b)Common Stock, $0.0001 par value per share · SNSE · NASDAQ
2023-03-2910-KSecurity registered under Section 12(b)Series A Preferred Stock Purchase Rights · NASDAQ
2023-03-2910-KStock registered under Section 12(b)Common Stock, $0.0001 par value per share · SNSE · NASDAQ
2022-11-0810-QStock registered under Section 12(b)Common Stock, $0.0001 par value per share · SNSE · NASDAQ
2022-08-0910-QStock registered under Section 12(b)Common Stock, $0.0001 par value per share · SNSE · NASDAQ
2022-05-1010-QStock registered under Section 12(b)Common Stock, $0.0001 par value per share · SNSE · NASDAQ
2022-03-1510-KStock registered under Section 12(b)Common Stock, $0.0001 par value per share · SNSE · NASDAQ
2021-11-1010-QStock registered under Section 12(b)Common Stock, $0.0001 par value per share · SNSE · NASDAQ
2021-08-1110-QStock registered under Section 12(b)Common Stock, $0.0001 par value per share · SNSE · NASDAQ
2021-05-1310-QStock registered under Section 12(b)Common Stock, $0.0001 par value per share · SNSE · NASDAQ

Similar stocks

Stock NameCountryMarket CapPE Ratio
COLLEGIUM PHARMACEUTICAL, INC (COLL)United States$0.737B24.57
Design Therapeutics, Inc. (DSGN)United States$0.766B-12.78
Wave Life Sciences, Inc. (WVE)$0.780B-5.56
Olema Pharmaceuticals, Inc. (OLMA)United States$0.790B-5.35
Aclaris Therapeutics, Inc. (ACRS)United States$0.792B-9.78
Verastem, Inc. (VSTM)United States$0.706B-1.71
Nuvectis Pharma, Inc. (NVCT)United States$0.705B-17.53
GERON CORP (GERN)United States$0.803B-12.14
IRONWOOD PHARMACEUTICALS INC (IRWD)United States$0.694B5.37
Climb Bio, Inc. (CLYM)United States$0.683B-13.03